Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M25.9Revenue $M1.4Net Margin (%)-70.8Altman Z-Score--
Enterprise Value $M47.2EPS $-0.3Operating Margin %67.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-327.1Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsY
Price/Sales21.05-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-81.6ROA % (ttm)-2.1Higher Current Ratio y-yN
Dividend Yield %0.5PEG--ROE % (ttm)-3.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M4.0ROIC % (ttm)2.1Gross Margin Increase y-yN

Gurus Latest Trades with DXR

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

DXR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DXR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Feldschuh Michael RichardExecutive VP 2015-08-12Buy500$6.22-3.7view
Feldschuh Michael RichardExecutive VP 2015-08-06Buy200$6.54-8.41view
Feldschuh Michael RichardExecutive VP 2015-08-04Buy583$6.49-7.7view
Feldschuh Michael RichardExecutive VP 2015-07-28Buy500$6.48-7.56view
Feldschuh Michael RichardExecutive VP 2015-07-24Buy500$6.68-10.33view
Meegan Diane MarieCorporate Secretary 2015-04-10Sell1,000$7.69-22.11view
FELDSCHUH JOSEPHPresident & CEO, 10% Owner 2015-04-01Buy300$5.665.83view
FELDSCHUH JOSEPHPresident & CEO, 10% Owner 2015-03-24Buy600$5.616.77view
FELDSCHUH JOSEPHPresident & CEO, 10% Owner 2015-03-16Buy3,500$5.793.45view
Meegan Diane MarieCorporate Secretary 2015-02-19Buy1,500$5.91.53view

Press Releases about DXR :

Quarterly/Annual Reports about DXR:

    News about DXR:

    Articles On GuruFocus.com
    Daxor Corporation Announces Filing of Form N-CSR for June 30, 2015 Aug 28 2015 
    Daxor Announces an Update on Its Stock Buyback Program and Changes in Marketing Aug 13 2015 
    Daxor Receives Notification of Patent Approval and Issues an Update on its Stock Buyback Program Mar 17 2015 
    Daxor Corporation Appoints Michael Feldschuh as Executive Vice President Dec 18 2014 
    Daxor Corporation Announces a Major Study With the Mayo Clinic Dec 11 2014 
    Daxor Corporation Announces Payment of a Dividend Nov 17 2014 
    Daxor Announces Publication of a Study Comparing Two Widely Used Surrogate Tests for Estimating Bloo Nov 03 2014 
    Daxor Corporation Announces Research Agreement With Virginia Commonwealth University on Burn Patient Oct 21 2014 
    3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
    Weekly 3-Year Low Stocks: PBR, NJ, DWA, DXR Feb 10 2013 

    More From Other Websites
    Daxor Corporation Announces Filing of Form N-CSR for June 30, 2015 Aug 28 2015
    Daxor Corporation Announces Filing of Form N-CSR for June 30, 2015 Aug 28 2015
    Daxor Announces an Update on its Stock Buyback Program and Changes in Marketing Aug 13 2015
    Daxor Announces an Update on Its Stock Buyback Program and Changes in Marketing Aug 13 2015
    Daxor Announces the receipt of a contract for the placement of a BVA-100 Blood Volume Analyzer at... Jun 23 2015
    Daxor Announces the Receipt of a Contract for the Placement of a BVA-100 Blood Volume Analyzer at... Jun 23 2015
    Daxor Announces the Receipt of a Contract for the Placement of a BVA-100 Blood Volume Analyzer at... Apr 28 2015
    Daxor Announces the Receipt of a Contract for the Placement of a BVA-100 Blood Volume Analyzer at... Apr 28 2015
    Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for... Apr 09 2015
    Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for... Apr 09 2015
    Daxor Receives Notification of Patent Approval and Issues an Update on its Stock Buyback Program Mar 17 2015
    Daxor Receives Notification of Patent Approval and Issues an Update on its Stock Buyback Program Mar 17 2015
    Daxor Corporation Announces Placement of Two BVA-100 Blood Volume Analyzers Mar 16 2015
    Daxor Corporation Announces Placement of Two BVA-100 Blood Volume Analyzers Mar 13 2015
    Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014 Mar 03 2015
    Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014 Feb 27 2015
    Daxor Corporation Announces Major Research Studies Jan 30 2015
    Daxor Corporation Appoints Michael Feldschuh as Executive Vice President Dec 18 2014
    Daxor Corporation Announces A Major Study with the Mayo Clinic Dec 11 2014
    Daxor Corporation Announces a Major Study With the Mayo Clinic Dec 11 2014

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK